Grifols SA (GRFS)
Grifols Market Cap : 5.574B for May 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cellectis SA | 368.24M |
| Biodexa Pharmaceuticals Plc | 2.042M |
| Amarin Corp. Plc | 300.49M |
| Akari Therapeutics Plc | 4.269M |
| NuCana Plc | 8.449M |
Market Cap Related Metrics
| PE Ratio | 11.58 |
| PS Ratio | 0.6463 |
| PEG Ratio | 0.0892 |
| Price to Book Value | 2.336 |
| Price to Free Cash Flow | 8.191 |
| Price | 8.19 |
| Earnings Yield | 8.63% |
| PEGY Ratio | 0.0877 |
| Operating PE Ratio | 3.927 |
| Normalized PE Ratio | 12.10 |